James L Trevaskis
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 25, 2025
A salute to innovation: exenatide in diabetes and obesity drug development at Amylin Pharmaceuticals.James L Trevaskis, David G Parkes, Andrew A Young
|Dec 05, 2018
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment.Matthieu Chodorge, Anthony J Celeste, Joseph Grimsby
|Nov 09, 2018
Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy.M Pilar Valdecantos, Laura Ruiz, Virginia Pardo
|Apr 15, 2017
Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats.James L Trevaskis, Chester Bittencourt Sacramento, Hani Jouihan
|Jan 17, 2017
Amylin/leptin synergy is absent in extreme obesity and not restored by calorie restriction-induced weight loss in rats.J L Trevaskis, C Wittmer, J Athanacio
|Jul 06, 2016
Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates.S J Henderson, A Konkar, D C Hornigold
Pageof 1
